Ion exchange and pH controlled drug delivery systems

Ion
exchange and pH controlled drug delivery systems

Session Objectives

By the end of this session, students will be able to:

       Explain the role of ion exchange resins in
the formulation of CRDF

       Discuss factors affecting the drug release
and pharmaceutical applications of IER
delivery systems

       Describe the process of pH variable on the
drug release from the dosage form

       Apply the principles of ion exchange resins
and pH dependent in dosage form 
development

Definition

       Ion
exchange is a reversible process in which ions of like sign are exchanged
between liquid and solid when in contact with a highly insoluble body. The drug
is released from the resinate by exchanging with  ions in the gastrointestinal fluid, followed
by drug diffusion Due to the presence of high molecular weight water insoluble
polymers, the resins are not absorbed by the body and are therefore inert

Advantages

       Ion-exchange
systems are advantageous for drugs that are highly susceptible to  degradation by enzymatic process

       A
major advantage of ion exchange system is low running cost

       It
requires little energy and the regenerated chemicals are cheap

       well
maintained, resin beds can last for many years before replacement

Limitations

       Limitation
is that the release rate is proportional to the concentration of the  ions present in the area of administration

       The
release rate of drug can be affected by variability in diet, water intake and
individual intestinal content

Classification of Ion exchange resin

1. Cation
exchange resin

a) Strong acid

b) Weak acid

2. Anion exchange resin

a) Strong base

b) Weak base

Ion Exchangers

Naturally occurring and synthetic

       Inorganic
ion exchangers have greater selectivity and better disposal options than
organic resin

       Organic
ion exchangers are reliable and efficient in water coolant systems

       Mineral
compounds such as bentonite, Kaolinite and Illite and Zeolites  such as analcite, chabazite, sodalite and
clinoptilolite are naturally  occurring
inorganic ion exchangers

       Zeolites,
Titanates and silico-titanates, transition metal hexacyanoferrates are  inorganic synthetic ion exchangers

       Polysaccharides
such as cellulose, algic acid, straw and peat, proteins such as  casein, keratin and collagen and carbonaceous
materials such as charcoals,  liquites and
coals are naturally occurring organic ion exchangers

Role of IER in Controlled Drug Delivery Systems

       The
major drawback of controlled release is dose dumping, resulting in increased
risk of  toxicity

       The
usage of IER during the development of controlled release formulations plays
a  significant role because of their drug
retarding properties and prevention of dose 
dumping

       The
drug resinates can also be used as a drug reservoir, which has caused a change
of the  drug release in hydrophilic
polymer tablets

       The
use of IER into drug delivery systems includes physico-chemical stability,
inert nature,  uniform size, spherical
shape assisting coating and equilibrium driven reproducible drug  release in ionic environment

       Drug
molecules attached to the resins are released by appropriate charged ions
in  the gastrointestinal tract, followed
by diffusion of free drug molecules out of the 
resin as shown below

Resin-
Drug +   + X +  à
Resin-…. X + + Drug +

Resin+
Drug + Y  à
Resin+…  Y + Drug

Where, X and Y are ions in the gastrointestinal tract.

       IER
have been used as drug carriers in pharmaceutical dosage forms for
controlled  release formulation

       The
prolonged release of the active drug is accomplished by providing a semi-  permeable coating around discrete, minute,
ion exchange resin particles with which 
the drug component has been complexed to form an insoluble drug resin
complex

 

       The
physical and chemical properties of the IER will release the drug more  uniformly than that of simple matrix formulations

Important Properties of IER

Ø  Particle
size and form

Ø  Porosity
and swelling

Ø  Cross
linkage

Ø  Available
capacity

Ø  Acid
base strength

Ø  Stability

Ø  Purity
and toxicity

Applications of IER

Pharmaceutical applications

       Taste
masking

       Eliminating
polymorphism

       Improving
the dissolution of poorly soluble drugs

       Improving
stability

       Improving
physical characteristics

Drug delivery applications

       Oral
drug delivery

       Nasal
drug delivery

       Transdermal
drug delivery

       Ophthalmic
drug delivery

Introduction to pH controlled systems

The variable nature of the chemical environment throughout
the length of the GIT is a further constraint on dosage form design.

Drugs administered orally would encounter a spectrum of pH
ranging from 7 in mouth, 1-4 in the stomach, and 5-7 in the small intestine.

Since most drugs are either weak acids or weak bases, their
release from formulation is pH dependent.

This type of system is designed for the controlled release
of acidic (or basic) drugs in GIT at a rate independent of the variation in GI
pH by formulating them with sufficient buffering agents.

It is prepared by first blending an acidic (or basic)
drug with one or  more buffering agents,
e.g. a primary, secondary, or tertiary salt of 
citric acid, granulating with appropriate excipients to form small  granules, and then coating the granules with
GI fluid-permeable  film-forming polymer,
e.g. cellulose derivatives.

Salts of amino acids, citric acid, phosphoric acid or
tartaric acid are commonly used.

The polymer coating controls the permeation of GI fluid. The
GI fluid permeating into the device is adjusted by the buffering agents to an
appropriate constant pH, at which the drug dissolves and is delivered through
the membrane at a constant rate regardless of the location of the device in the
alimentary canal.

pH
Activated Drug Release

       This
type of drug delivery permits targeting the delivery in a region with selected
pH

       In
this system the gastro intestine liable drug is coated with an  intestinal fluid soluble and insoluble
polymer i.e. Ethyl cellulose and  Hydroxy
Methyl Cellulose Phthalate (HMCP)

       The
HMCP polymer gets degraded in the small intestine and produces  pores in the ethyl cellulose polymer coating

       The
drug then releases from the micro porous membrane at a  controlled rate

Summary

       Ion
exchange is a reversible process in which ions of like sign are  exchanged between liquid and solid when in
contact with a highly  insoluble body

       The
drug is released from the resinate by exchanging with ions in the gastrointestinal
fluid, followed by drug diffusion

       The
use of IER into drug delivery systems includes physico-chemical  stability, inert nature, uniform size and
spherical shape which exhibits 
reproducible drug release in ionic environment

       The
physical and chemical properties of the IER will release the drug more
uniformly than that of simple matrix formulations

       The
pharmaceutical applications of IER controlled delivery systems  includes : taste masking of drug, improving
dissolution of poorly  soluble drugs,
physical characteristics and stability

       pH
activated drug delivery permits targeting the drug release in a  region with selected pH. It is designed for
the controlled release of  acidic or
basic drugs independent of G.I. pH variablity

For PDF Notes Click on Download Button

Leave a Comment